These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A review of brain oscillations in cognitive disorders and the role of neurotransmitters. Başar E; Güntekin B Brain Res; 2008 Oct; 1235():172-93. PubMed ID: 18640103 [TBL] [Abstract][Full Text] [Related]
25. Stress, neurotransmitters, and hormones neuroendocrine and genetic mechanisms. Preface. Kvetnanský R Ann N Y Acad Sci; 2008 Dec; 1148():xiii-xiv. PubMed ID: 19120087 [No Abstract] [Full Text] [Related]
26. Brain stimulation for the treatment of psychiatric disorders. George MS; Nahas Z; Borckardt JJ; Anderson B; Foust MJ; Burns C; Kose S; Short EB Curr Opin Psychiatry; 2007 May; 20(3):250-4; discussion 247-9. PubMed ID: 17415078 [TBL] [Abstract][Full Text] [Related]
27. [New development in glial cell research]. Kudo Y Brain Nerve; 2007 Jul; 59(7):655-67. PubMed ID: 17663136 [TBL] [Abstract][Full Text] [Related]
28. Treatment of common mental disorders in primary care in low- and middle-income countries. Siddiqi K; Siddiqi N Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):957-8. PubMed ID: 17540425 [TBL] [Abstract][Full Text] [Related]
29. 'The emergence of neurotransmitters as immune modulators': letter to Rafael Franco and colleagues. Straub RH; Jessop DS Trends Immunol; 2008 Jul; 29(7):303; author reply 304-5. PubMed ID: 18524681 [No Abstract] [Full Text] [Related]
30. [Comorbid addictions in bipolar disorder]. Gorwood P; LeStrat Y; Wohl M Encephale; 2008 Jun; 34 Suppl 4():S138-42. PubMed ID: 18707936 [No Abstract] [Full Text] [Related]
31. Transcranial magnetic stimulation: a device intended for the psychiatrist's office, but what is its future clinical role? Shah DB; Weaver L; O'Reardon JP Expert Rev Med Devices; 2008 Sep; 5(5):559-66. PubMed ID: 18803466 [TBL] [Abstract][Full Text] [Related]
32. The incidence of seizures following Deep Brain Stimulating electrode implantation for movement disorders, pain and psychiatric conditions. Coley E; Farhadi R; Lewis S; Whittle IR Br J Neurosurg; 2009 Apr; 23(2):179-83. PubMed ID: 19306174 [TBL] [Abstract][Full Text] [Related]
36. The neurotransmitter cycle and quantal size. Edwards RH Neuron; 2007 Sep; 55(6):835-58. PubMed ID: 17880890 [TBL] [Abstract][Full Text] [Related]
37. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. López-Moreno JA; González-Cuevas G; Moreno G; Navarro M Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831 [TBL] [Abstract][Full Text] [Related]
39. [Involvement of central neurotransmission systems in schizophrenia]. Martres MP Therapie; 2008; 63(3):177-85. PubMed ID: 18718209 [TBL] [Abstract][Full Text] [Related]
40. Use of clinical and service indicators to decrease the treatment gap for mental disorders: a global perspective. Saxena S Epidemiol Psichiatr Soc; 2008; 17(4):267-9. PubMed ID: 19024715 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]